
|Articles|April 23, 2020
COVID-19: Sun Pharmaceuticals business update
Author(s)Mark Hagler
Advertisement
Mark Hagler, senior vice president, head of Ophthalmics, Oncology and LTC, at Sun Pharmaceuticals, shares a business update on how the company has responded and continued operations during the coronavirus pandemic.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Tinlarebant NDA submission completed for Stargardt disease type 1, targeting first approved therapy
2
Recognizing biomarkers of Alzheimer Disease using OCTA
3
Midyear cataract check-in: What 2026 has brought to the OR and beyond
4
Durability With Aflibercept 8 mg in Retinal Vascular Diseases
5





















